Oncology Innovations Fund Gp Llc Mpm serves as Executive at Werewolf Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Oncology Innovations Fund Gp Llc Mpm has executed 9 insider transactions totaling $528.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 25, 2025 involved selling 42,533 shares valued at $39.1K.
Oncology Innovations Fund Gp Llc Mpm currently holds 5,125,770 shares of Werewolf Therapeutics, Inc. (HOWL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Oncology Innovations Fund Gp Llc Mpm has been a net seller of HOWL stock. They have purchased $0 and sold $528.1K worth of shares.
Oncology Innovations Fund Gp Llc Mpm's most recent insider trade was on Nov 25, 2025, when they sold 42,533 shares at $0.92 per share.
Get notified when new Form 4 filings are submitted
| $0.98 |
| Discretionary |
| Nov 21, 2025 | HOWL | $53.4K | Sale | 64,331 | $0.83 | Discretionary |
| Nov 20, 2025 | HOWL | $36.6K | Sale | 41,152 | $0.89 | Discretionary |
| Nov 19, 2025 | HOWL | $62.3K | Sale | 66,324 | $0.94 | Discretionary |
| Nov 18, 2025 | HOWL | $48.9K | Sale | 52,627 | $0.93 | Discretionary |
| Nov 17, 2025 | HOWL | $54.2K | Sale | 57,061 | $0.95 | Discretionary |
| Nov 14, 2025 | HOWL | $57.3K | Sale | 61,640 | $0.93 | Discretionary |
| Nov 13, 2025 | HOWL | $89.1K | Sale | 90,951 | $0.98 | Discretionary |